跳到正文
原文
MedTech Dive 器械媒体· Susan Kelly·· 2 小时前AI 评分45

J&J 在美国医院安装首个 Ottava 手术机器人

J&J to install first Ottava robot in US hospital

AI 导读

Johnson & Johnson 宣布 Memorial Hermann-Texas Medical Center 将成为美国首个安装其 Ottava 手术机器人的医院。Ottava 于 2026 年 7 月获得 FDA 的 de novo 批准,可用于 10 种上腹部一般手术。该系统旨在改善手术流程效率,解决医院面临的空间和资源挑战。

正文

An article from site logo

Dive Brief

The commercial agreement with Memorial Hermann-Texas Medical Center comes in the same week that rival Medtronic revealed expanded FDA clearance for its Hugo robot in general surgical procedures.

Published Nov. 20, 2026

By

Three components of Johnson & Johnson's Ottava robotic surgery system are displayed.

Johnson & Johnson's Ottava surgical robot received FDA de novo authorization in July 2026. Courtesy of Johnson & Johnson

This audio is auto-generated. Please let us know if you have feedback.

Dive Brief:

  • Johnson & Johnson said Thursday the first hospital to commercially install and use its Ottava robotic surgery system will be Memorial Hermann-Texas Medical Center.
  • Tim Schmid, J&J’s worldwide chairman for medtech, said in a statement that the milestone is a significant step toward the company’s ambition to lead in surgical robotics. 
  • The Houston-based hospital will be the first in the U.S. to use Ottava as part of J&J’s early access commercial program. 

Dive Insight:

Surgery is a large global business for J&J, which is mounting a major push into robotics. Like its medtech rival Medtronic, J&J is now taking on longtime robotic surgery leader Intuitive in the U.S. market.

The commercial agreement with Memorial Hermann-Texas follows the Ottava soft tissue robot’s de novo authorization from the Food and Drug Administration in July, when it received the go-ahead for use in 10 general surgery procedures within the upper abdomen.

Earlier this week, Medtronic revealed that it won FDA clearance for its Hugo robot in upper abdominal general surgery. The action marks a key expansion for Hugo, which gained its initial FDA clearance in December for urologic procedures such as prostate removal. 

J&J said Ottava represents more than a new technology offering. The system was designed to improve workflow and procedural efficiencies for healthcare teams, Schmid said. The robot’s four arms are integrated into a standard-sized surgical table to save space.

Ottava addresses some of the most persistent challenges facing hospitals, including operating room space constraints, workflow complexity, growing demand for robotic surgery and increasing pressure on healthcare resources, J&J said.

J&J’s FDA authorization includes Roux-en-Y gastric bypass, gastrectomy, cholecystectomy, splenectomy, gastric sleeve, small bowel resection, appendectomy, lysis of adhesions, fundoplication and hiatal hernia repair. 

Memorial Hermann-Texas Medical Center was a clinical trial site in Ottava’s investigational device exemption program that supported regulatory authorization. J&J said it will continue the robot’s commercial launch with select customers in the U.S., while working to evaluate the platform in additional indications.

来源:MedTech Dive 器械媒体 · medtechdive.com